Ignite Creation Date:
2024-05-06 @ 2:09 AM
Last Modification Date:
2024-10-26 @ 11:15 AM
Study NCT ID:
NCT01986348
Status:
TERMINATED
Last Update Posted:
2023-01-26
First Post:
2013-10-17
Brief Title:
Study Evaluating the Efficacy and Safety of Selinexor KPT-330 in Participants With Recurrent Gliomas
Sponsor:
Karyopharm Therapeutics Inc
Organization:
Karyopharm Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03-03
Start Date Type:
ACTUAL
Primary Completion Date:
2020-01-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-01-23
Completion Date Type:
ACTUAL
First Submit Date:
2013-10-17
First Submit QC Date:
November 11 2013
Study First Post Date:
2013-11-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-08-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-24
Last Update Post Date:
2023-01-26
Last Update Post Date Type:
ACTUAL